The novel approach of the medication represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide700618.blog-a-story.com/23893445/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment